Spero Therapeutics, Inc. Business Operations Contracts & Agreements
5 Contracts & Agreements
- Indemnification Agreements (1 contract)
- Management Agreements (1)
- Sales Agreements (1)
- Termination Agreements (2)
- Revenue Interest Termination Agreement, dated June 7, 2022, by and between Spero Therapeutics, Inc., entities managed by HealthCare Royalty Management, LLC and HCR Collateral... (Filed With SEC on June 7, 2022)
- Revenue Interest Financing Agreement, dated September 29, 2021, by and between Spero Therapeutics, Inc. and entities managed by HealthCare Royalty Management, LLC (Filed With SEC on September 30, 2021)
- Controlled Equity Offering Sales Agreement, dated March 11, 2021, by and between the Registrant and Cantor Fitzgerald & Co (Filed With SEC on March 11, 2021)
- Termination and Release, dated April 14, 2017, by and between the Registrant and John Tomayko, M.D (Filed With SEC on October 6, 2017)
- Form of Director and Officer Indemnification Agreement (Filed With SEC on October 6, 2017)
